Clinical Cancer Drugs

Clinical Cancer Drugs publishes original research and (as well as) expert reviews, and thematic issues in all core areas of translational and clinical cancer drug research.

The journal publishes pre-clinical and clinical studies on the development of new anti-cancer agents. Clinical ...read more

  • ISSN (Print): 2212-697X
  • ISSN (Online): 2212-6988
  • Issues: 11 , 2025
1.3
Download PDF Flyer
Clinical Cancer Drugs
Explore Articles
About Journal
For Authors
For Editors
For Reviewers

Early View

Review Article
Harnessing the Potential of Metallic Nanoparticles for Modulating the Tumor Microenvironment and Immune Responses in Breast Cancer Immunotherapy

Authors: Shatrudhan Prajapati and Shikha Yadav*

DOI: 10.2174/012212697X334574250107090812

Published on: January 20, 2025

Letter to the Editor
Advancements in Cancer Therapeutics: Emerging Agents and Combination Strategies in Drug Discovery

Authors: Afzal Hussain* and Ashfaq Hussain

DOI: 10.2174/012212697X361870250113043318

Published on: January 14, 2025

Review Article
Biomaterials used to Deliver Drugs for Colon Cancer Management

Authors: Namita Badoniya and Manu Sharma*

DOI: 10.2174/012212697X299780240905141609

Published on: December 24, 2024

Research Article
Efficacy Assessment of Sulfated Flavanol Functionalized Silver Nanoparticles against MCF-7 Breast Cancer

Authors: Shweta Rajawat*, B. Ramchandran and M.M. Malik

DOI: 10.2174/012212697X345534241121082505

Published on: December 2, 2024

Mini-Review Article
A Quest for the Dual Role of Lymphatic Transport in Cancer: From Immune Surveillance to Tumour Dissemination

Authors: Faiza Ismail, Mohd Mustafa, Irfan Qadir Tantry and Safia Habib*

DOI: 10.2174/012212697X339680241118072504

Published on: November 19, 2024

Review Article
PROTAC and PROTAB: Revolutionizing Cancer Therapy by Targeted Protein Degradation

Authors: Swati Verma*, Sarvesh Paliwal and Debashish Paramanick

DOI: 10.2174/012212697X323611241109143952

Published on: November 15, 2024

Review Article
Revolutionizing Glioblastoma Immunotherapy Conquering Transport and Biological Challenges, Innovating Combinatorial Approaches for Unprecedented Treatment Success

Authors: Shatrudhan Prajapati and Shikha Yadav*

DOI: 10.2174/012212697X332800241103174044

Published on: November 11, 2024

Research Article
Investigation of Novel Quinoline Derivatives Targeting Epidermal Growth Factor Receptors as Anticancer Agents a Computational Approach

Authors: Ganesh S. Mhaske*, Diksha R. Sonkusare, Asmita D. Ganage, Shraddha M. Toraskar, Siddhesh V. Rokade, Shweta B. Dighe and Pramod H. Sakpal

DOI: 10.2174/012212697X335334241101023647

Published on: November 7, 2024

Research Article
Synergistic Action of Thymol-citral is Associated with Cell Cycle Arrest and Intracellular ROS Generation in A549 Cells

Authors: Devasahayam Jaya Balan, Chandramohan Kiruthiga, Mahalingam Jeyakumar and Kasi Pandima Devi*

DOI: 10.2174/012212697X326412241017124450

Published on: October 24, 2024

Research Article
PNU-74654 Enhanced the Antiproliferative Activity of Gemcitabine by Targeting Wnt/β-Catenin Pathway in Pancreatic Cancer

Authors: Sajjad Sharifi, Shima Mehrabadi, Farzad Rahmani, Abolfazl Nosrati-Tirkani, Shadi Khorrami, Majid Khazaei, Seyed Mahdi Hassanian, Majid Rajabian, Nadia Boromand, Seyed Mohammad Reza Parizadeh, Gordon A. Ferns and Amir Avan*

DOI: 10.2174/012212697X293676240916114229

Published on: October 21, 2024

Editorial
Unlocking Hope: The Promise of CAR-T Cell Therapy in Cancer Treatment

Authors: Prabhjot Kaur, Anish Soni and Naresh Kumar Rangra*

DOI: 10.2174/012212697X331142240919060817

Published on: September 25, 2024

No Record Found

LOADING